Odontoprev EBITDA
The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Odontoprev (ODPV3.SA) as of Oct 14, 2026 is 721.27 M BRL. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 683.36 M BRL — a change of 5.55% (higher).
Get this data via API
Financial Data API
EBITDA
721.27 MBRL
YoY
5.55%
Last updated:
The Odontoprev EBITDA history
3 Years
10 Years
25 Years
Max
| YEAR | EBITDA | YoY |
|---|---|---|
| 721.27 MBRL | +5.55% | |
| 683.36 MBRL | -15.32% | |
| 807.03 MBRL | +57.64% | |
| 511.96 MBRL | -9.20% | |
| 563.85 MBRL | +5.16% | |
| 536.18 MBRL | +31.27% | |
| 408.45 MBRL | +3.87% | |
| 393.24 MBRL | -185.85% | |
| -458.04 MBRL | -259.12% | |
| 287.86 MBRL | -10.01% | |
| 319.87 MBRL | +13.56% | |
| 281.69 MBRL | — |
Odontoprev Stock analysis
Frequently Asked Questions about Odontoprev stock
EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Odontoprev is 721.27 M BRL in 2025.
EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Odontoprev changed from 683.36 M BRL to 721.27 M BRL, representing a 5.55% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Odontoprev since 2006 – with annual values, charts, and detailed analysis.
EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.
EBITDA = EBIT + Depreciation & Amortization
EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s BRL is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Odontoprev historically and in real time.
Income Statement — Odontoprev
All Key Metrics — Odontoprev
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth